Skip to content
ClinCalc Pro
Menu
Inhaled Corticosteroid

Fluticasone Propionate

Brand names: Flixotide, Flixonase (nasal)

Fluticasone propionate is an inhaled corticosteroid used in children for the maintenance prophylaxis of asthma; this page covers the inhaled preventer rather than systemic or nasal preparations.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

A potent glucocorticoid that, after delivery to the airways, binds glucocorticoid receptors to suppress airway inflammation, reduce mucosal oedema and decrease bronchial hyper-responsiveness.

Prescribing in practice

  • Inhaled corticosteroids can cause growth retardation in children, so use the lowest effective dose, monitor height and review the need for treatment regularly.
  • Use an age-appropriate spacer (with facemask in young children) and correct inhaler technique to maximise lung deposition and reduce oropharyngeal effects.
  • It is a preventer, not a reliever, and must be taken regularly even when the child is well.

Monitoring

Monitor the child's height and growth, asthma control and inhaler technique at routine reviews.

Counselling the patient

  • Rinse the mouth and spit out after each dose to reduce the risk of oral thrush and hoarseness.
  • Use every day as a preventer, not for sudden breathlessness.
  • Always use the prescribed spacer device and bring it to reviews so technique can be checked.

Evidence & guidelines

Inhaled corticosteroids are first-line preventer therapy in paediatric asthma per NICE/BTS-SIGN guidance.

Reference: BTS/SIGN Asthma Guidelines 2019; MHRA Drug Safety Update 2018 (fluticasone/ritonavir); NICE NG80; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.